• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 UNK HIP FEMORAL STEM CORAIL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 UNK HIP FEMORAL STEM CORAIL Back to Search Results
Catalog Number UNK HIP FEMORAL STEM CORAIL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 11/20/2020
Event Type  Injury  
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: kaseb mh, shafiee sh, shamabadi a, aminjavaheri sa, mortazavi smj.Cementless total hip arthroplasty in haemophilia patients through direct anterior approach.Haemophilia.2021 mar;27(2):e239-e244.Doi: 10.1111/hae.14224.Epub 2021 feb 2.Pmid: 33529379.Objective and methods: authors conducted a retrospective review of 12 patients diagnosed with haemophilia, who received 14 total hip arthroplasties (tha), to assess outcomes of tha using direct anterior approach (daa) in patients with haemophilia.Patients received non-cemented hip prosthesis from one of three manufacturers, with depuy pinnacle cup and corail femoral stem being used in seven patients.Liner and femoral head details were not provided.The patients were all male, and data was provided by case number and age of the patients.Results: the mean duration of clinical follow-up was 69 months (with a range of 36 to 96 months).Survey scores were good.Only one patient with simultaneous bilateral daa tha required blood transfusion.It was observed that complications of cementless tha using daa in haemophilia patients with hip arthropathy are comparable to other surgical approaches, yet the complication of bleeding in this approach might be less.Depuy hip complications by case number: case 5: age 42, simultaneous bilateral tha, experienced severe haemorrhage, treated with blood transfusion case 11: age 26, intraoperative calcar femur fracture, non-displaced, treated with orif cerclage wire.
 
Manufacturer Narrative
Product complaint #: (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.This complaint was opened to document complaints derived through a journal article review.Follow-ups were done to try and obtain additional information from the author of the journal article.No further information was received.Device history lot: a manufacturing record evaluation (mre), was not possible because the required lot code was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK HIP FEMORAL STEM CORAIL
Type of Device
FEMORAL STEM
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
Manufacturer (Section G)
DEPUY ORTHOPAEDICS, INC. 1818910
700 orthopaedic dr.
warsaw IN 46581 0988
Manufacturer Contact
kate karberg
700 orthpaedic dr.
warsaw, IN 46581
3035526892
MDR Report Key15056217
MDR Text Key296172683
Report Number1818910-2022-13444
Device Sequence Number1
Product Code LPH
Combination Product (y/n)N
Reporter Country CodeIR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK HIP FEMORAL STEM CORAIL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 07/01/2022
Initial Date FDA Received07/19/2022
Supplement Dates Manufacturer Received08/23/2022
Supplement Dates FDA Received08/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-